Phase I Study Of Bevacizumab, Sorafenib, And Low-Dose Cyclophosphamide (Cyc) In Children And Young Adults With Refractory Solid Tumors.
JOURNAL OF CLINICAL ONCOLOGY(2011)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
JOURNAL OF CLINICAL ONCOLOGY(2011)